Mytos

Mytos is at the forefront of the bio-manufacturing revolution, developing bespoke automated systems designed to industrialize the production of regenerative medicines. By moving cell culture from manual labor to precision robotics, Mytos is dramatically reducing the cost and complexity of advanced therapies, aiming to make them accessible to patients worldwide.

Backed by industry-leading investors like Y Combinator and fueled by a significant $24M funding round, the company offers a unique workspace where hardware engineering meets biology. Mytos is the ideal destination for professionals looking to make a tangible impact on the future of healthcare through technical innovation.

• Competitive Equity Packages
• Comprehensive Health Insurance
• Collaborative Cross-Disciplinary Environment
• Cutting-edge Robotics Lab Access
• Professional Development Opportunities

Scientific Rigor

We prioritize empirical evidence and high-quality data in every aspect of our cell manufacturing processes to ensure the highest standards of safety and efficacy.

Automation Excellence

By integrating custom robotics with biological workflows, we strive to remove human error and scale regenerative therapies that were previously unreachable.

Collaborative Innovation

Our team bridges the gap between deep-tech engineering and life sciences, fostering a culture where engineers and scientists learn from one another daily.